Menu
ncarol.com
  • Home
  • Music
  • Asheville Music
  • Entertainment
  • Real Estate
  • Business
  • Technology
  • Health
  • Artificial Intelligence
ncarol.com

Enhancing Mental Health Medication Adherence with Meticap
ncarol.com/10262303

Trending...
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki - 122
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs - 114
  • Kestrel Ridge Health Launches AI-Powered Ophthalmology Workforce Forecasting Platform - 109
In recent developments, pharmacists now have access to a revolutionary tool called Meticap, designed to support patients in taking their medications consistently and accurately.

CHARLOTTE, N.C. - ncarol.com -- Adherence to prescribed medication regimens is a critical component of mental health treatment, yet it often presents challenges for patients. In recent developments, pharmacists now have access to a revolutionary tool called Meticap (https://meticap.com/s/Home), designed to support patients in taking their medications consistently and accurately.

Meticap: A Game-Changer in Medication Adherence
This reusable medication timing cap attaches effortlessly to each of the patients' existing 1-Clic® vial caps, allowing patients to store their prescription medications securely in their original container to ensure they adhere to their prescribed medication schedules. Meticap records day of week and hours, as well as Last Dose Taken and Next Dose.

More on ncarol.com
  • ViewDNS.info Launches Monitors, Alerting Teams the Moment Something Changes on Their Domains
  • Philadelphia-Area Entrepreneur Nouho M Kanneh Builds $37 Million Net Worth Across Real Estate, E-Commerce and Retail
  • Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
  • The World's No.1 Superstar® Brings Christmas Back in Grand Style with Music, Cinematic Glamour, and Luxury Fashion
  • New Six-Figure Media Agreement Builds Powerful Momentum, Expanding Government Contracts, FBI Access and Growing AI Recognition: Cyabra (NAS DAQ: CYAB)

Meticap boasts a low-tech design with six patented innovations, eliminating the need for beeps, lights, batteries, or complicated apps - and has the ability to track multiple doses throughout the day thanks to the hour and day dials. This reduces complexity for patients, avoids triggering sounds and visual interference, and is a low-cost, easy-to-implement solution that positions pharmacies as problem-solvers and partners in healthcare.

The Importance of Adherence in Mental Health Treatment
Maintaining consistent adherence to prescribed medications is essential for managing symptoms and promoting overall well-being. However, factors such as cognitive impairment, mood fluctuations, and stigma surrounding mental health conditions can pose significant barriers to adherence. Pharmacists recognize these challenges and play a crucial role in supporting patients in overcoming them. Devices like Meticap that help patients maintain their independence, build confidence and comfort in their routines, and stay adherent to their medication schedules are a game-changer.

More on ncarol.com
  • Christmas Beats Summer in Paris: Travel Photoshoots Peak on Dec. 30
  • Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
  • Jamie Foxx's SKVLK Fest Sets the Record Straight on Stabbing Reports Following Star-Studded Celebration
  • Andrew Balzano Releases One of My Life's Passions: Classics and Mysteries, a Fan's Guide to Great Mysteries Worth Rewatching
  • The 4th Annual Newark Summit for Economic Development, Placemaking & Innovation Returns on December 8th

Integrating Meticap into Pharmacy Practice
Pharmacists are uniquely positioned to incorporate Meticap into their practice to enhance medication adherence among patients with mental health conditions. Meticap offers two modes via a flippable top ring for patients to track their medication doses: marking the last dose taken or queuing up the next scheduled dose. For individuals taking medications such as painkillers or anxiety medications, the "Last Dose Taken" option is ideal for ensuring they adhere to prescribed dosing schedules without the risk of accidental misuse.

Advancing Mental Health Care Through Innovation
Meticaps are available in 100-pack units (NET 30, fully refundable) and there are several retail display options, including video, that pharmacies can order to educate consumers. Pharmacies can easily add Meticap as an additional SKU to their point-of-sale system. Meticaps can be leveraged in marketing campaigns for customer acquisition and differentiation. Pharmacists interested in implementing Meticap can place an order and receive training materials for technicians by contacting orders@meticap.com.

Contact
Meticap
***@meticap.com


Source: Meticap

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
  • Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
  • PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
  • Tonight in Asheville: KayeDinero Drops "Underground" and Opens Beat Catalog
  • KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
  • Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • Prince's Collaborator Shelby J To Be A Special Guest For "a Deadly Proposal" Red Carpet
  • Rent a Truck or Hire Movers? New Data Shows Fuel Now Makes Up to 40% of DIY Moving Costs
  • 7th Annual RACE INDUSTRY WEEK Returns Nov. 30 – Dec. 3 With Free Live Webinars From Racing Leaders
  • Club Wyndham Research Identifies the "Holiday Rewind Effect": 93% of Parents Recreate Their Own Childhood Holidays for Their Kids
  • IEI Rugged IP66 Panel PC Brings Real-Time Visibility to Heavy-Duty Mining Fleets
  • AQUALIS of Morrisville, NC, Acquires Full Circle Environmental of Garner, NC
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Building a Technology Powerhouse-From AI Drones and Global Acquisitions to Defense, Enterprise Software and the Future of Autonomous Operations $ZENA
  • Shelter Structures America backs MATRA Second Life Project to turn retired tent vinyl into homes for displaced families
  • P-Wave Press Announces Becoming Dad: Reflections for New Fathers by L. A. Davenport
  • Logicraft Launches FuelDeck™, AI That Turns Aviation Fuel Tickets Into One Traceable Ledger
  • Inaugural OC Tech Week Draws 3,000 From 12 Countries, Sends Finalist to $1M Startup World Cup
  • Award-Winning American Hotelier Opens Art-Filled Luxury Cottage in Norfolk, England
_catLbl0 _catLbl1

Popular on ncarol.com

  • Constantine "Costa" Kapothanasis II Acquires The Lubri-Loy Company, Carrying a 77-Year-Old American Lubricant Brand Into Its Next Era - 267
  • Parade of Homes Winners Announced - 247
  • Nious Media Expands Independent Entertainment Network Through Gaming, Music and Digital Storytelling - 191
  • North Carolina Author Carrie Sybert Celebrates Three Published Books - 180
  • Air Force Veteran Sean Douglas Delivers Powerful Suicide Prevention Presentations to Hundreds of Marines at Camp Pendleton - 127
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki - 122
  • 450 Million Revenue Run Rate, Global Telecom Reach and a New Digital Growth Opportunity Take Center Stage: IQSTEL, Inc. (N A S D A Q: IQST) - 116
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs - 114
  • Renew Integrative Health Publishes Updated Peptide Therapy Guide to Help Patients Understand Their Options - 113
  • UK Financial Ltd Announces Two-for-One Upgrade of Maya 3 to Maya 3G Token Using Chainlink Cross-Chain Technology - 111

Similar on ncarol.com

  • Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
  • Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
  • Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute